A Phase II Randomized, Placebo-Controlled Trial of Polyphenon E to Evaluate Bladder Tissue Levels of EGCG

Trial Profile

A Phase II Randomized, Placebo-Controlled Trial of Polyphenon E to Evaluate Bladder Tissue Levels of EGCG

Discontinued
Phase of Trial: Phase II

Latest Information Update: 21 Jun 2017

At a glance

  • Drugs Polyphenon E (Primary)
  • Indications Bladder cancer
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 31 Jul 2015 New trial record
    • 19 May 2015 Results presented at the 110th Annual Meeting of the American Urological Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top